In the BioHarmony Drug Report Database

"Preview" Icon

Nortriptyline

Aventyl, Pamelor (nortriptyline) is a small molecule pharmaceutical. Nortriptyline was first approved as Aventyl on 1982-01-01. It is used to treat anxiety disorders, attention deficit disorder with hyperactivity, depressive disorder, enuresis, and pain amongst others in the USA. The pharmaceutical is active against sodium-dependent noradrenaline transporter and sodium-dependent serotonin transporter. In addition, it is known to target G protein-activated inward rectifier potassium channel 4, ATP-sensitive inward rectifier potassium channel 10, and G protein-activated inward rectifier potassium channel 2.

 

Trade Name

 

Aventyl, Pamelor
 

Common Name

 

nortriptyline
 

ChEMBL ID

 

CHEMBL445
 

Indication

 

anxiety disorders, attention deficit disorder with hyperactivity, depressive disorder, enuresis, pain, psychotic affective disorders
 

Drug Class

 

Antidepressants (dibenzo[a,d]cycloheptane derivatives)

Image (chem structure or protein)

Nortriptyline structure rendering